PapersFlow Research Brief
Blood Pressure and Hypertension Studies
Research Guide
What is Blood Pressure and Hypertension Studies?
Blood Pressure and Hypertension Studies is a field in cardiology that examines the management of hypertension through antihypertensive drugs, cardiovascular risk factors, renal denervation, and its links to diabetes mellitus, alongside global burden assessments, clinical guidelines, and associations with cardiovascular events.
This field encompasses 133,394 works focused on hypertension prevention, detection, evaluation, and treatment. Key areas include the impact of hypertension on diabetes mellitus and cardiovascular events, as well as interventions like renal denervation and antihypertensive drugs. Clinical guidelines such as those from the Joint National Committee and European societies provide evidence-based approaches to blood pressure management.
Topic Hierarchy
Research Sub-Topics
Renal Denervation for Hypertension
This sub-topic examines catheter-based renal nerve ablation as a device therapy for resistant hypertension, including randomized trial outcomes, blood pressure reductions, and safety profiles. Researchers study long-term efficacy, patient selection, and anatomical considerations.
Antihypertensive Combination Therapy
Studies investigate optimal drug combinations, including RAS inhibitors with calcium channel blockers or diuretics, for blood pressure control and cardiovascular protection. Research covers fixed-dose formulations, adherence improvement, and comparative effectiveness.
Hypertension in Diabetes Mellitus
This area explores the bidirectional relationship between hypertension and type 2 diabetes, including shared pathophysiology, albuminuria progression, and cardioprotective agents like SGLT2 inhibitors. Researchers analyze glycemic control impacts on vascular complications.
Global Burden of Hypertension
Epidemiological research quantifies hypertension prevalence, awareness, treatment, and control rates across world regions using standardized measurement protocols. Studies project future burdens attributable to aging, obesity, and socioeconomic factors.
Hypertension Clinical Practice Guidelines
This sub-topic analyzes evidence-based recommendations from JNC, ESC/ESH, and other societies on diagnosis, risk stratification, treatment targets, and lifestyle interventions. Researchers evaluate guideline implementation gaps and comparative effectiveness.
Why It Matters
Blood Pressure and Hypertension Studies informs clinical practice by establishing targets like systolic blood pressure of 140 mm Hg or higher in persons older than 50 years, as outlined in Chobanian et al. (2003) in 'The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>', which has guided prevention strategies worldwide with 25,419 citations. These studies quantify the global burden, with Roth et al. (2020) in 'Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019' detailing hypertension's role in cardiovascular disease prevalence. In practice, tools like the DHIS2 hypertension package enable patient tracking and outcome monitoring in diabetes control projects, while INTERHEART findings by Yusuf et al. (2004) show hypertension accounts for substantial myocardial infarction risk across 52 countries.
Reading Guide
Where to Start
'The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>' by Chobanian (2003), as it provides foundational guidelines on prevention, detection, evaluation, and treatment with clear key messages like systolic BP focus for those over 50.
Key Papers Explained
Chobanian et al. (2003) in 'The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>' and 'Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure' establish JNC 7 baselines, which Mancia et al. (2013) in '2013 ESH/ESC Guidelines for the management of arterial hypertension' and Williams et al. (2018) in '2018 ESC/ESH Guidelines for the management of arterial hypertension' build upon with European evidence updates. Yusuf et al. (2004) in 'Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study' complements by quantifying hypertension's risk factor role. Cockcroft and Gault (1976) in 'Prediction of Creatinine Clearance from Serum Creatinine' supports renal assessments in these contexts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints like '2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults' and 'The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)' target <130/80 mmHg universally. News highlights baxdrostat for resistant hypertension and team-based control efforts at VUMC.
Papers at a Glance
In the News
Scientists reveal breakthrough blood pressure treatment ...
Date:August 31, 2025Source:University College LondonSummary:A breakthrough pill, baxdrostat, has shown remarkable success in lowering dangerously high blood pressure in patients resistant to standa...
Researcher offers new therapeutic for treating high blood ...
**Research:**Hypertension, specifically the neurogenerative kind **Research Funding:**An R01 grant from the National Heart, Lung and Blood Institute
Top heart and brain research for 2025 found new ways to ...
“It’s interesting to note that investigators who at some point in their careers have received research funding from the American Heart Association were among the authors of 12 out of the 17 highlig...
VUMC to implement team-based effort to improve high blood ...
# VUMC to implement team-based effort to improve high blood pressure control
New scan could help millions with hard-to-treat high blood ...
The study was conducted at UCL and UCLH and was funded by the MRC and the NIHR University College London Hospitals Biomedical Research Centre.
Code & Tools
A DHIS2 package that can be used by any team working on hypertension and/or diabetes control projects. The package consists of a**DHIS2 Tracker pro...
Blood Pressure (BP) is an important cardiovascular health indicator. BP is usually monitored noninvasively with a cuff-based device, which can be b...
This data set contains PPG recordings from 56 subjects who were not hospitalized during data collection. This dataset is intended to support the de...
This repository contains sample data and explanatory for processing the**CAS-BP**dataset released alongside the publication " Cuffless Blood Pressu...
# Large-scale Evidence Generation and Evaluation across a Network of Databases for Hypertension Stepped-care Treatment (LEGEND-HTNStepCare) Stud...
Recent Preprints
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
METHODS: A comprehensive literature search was conducted from December 2023 to June 2024 to identify clinical studies, reviews, and other evidence performed on human subjects that were published s...
The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)
The Japanese Society of Hypertension (JSH) Guidelines for the Management of Hypertension 2019 (JSH2019) have been revised, and the JSH Guidelines for the Management of Elevated Blood Pressure and H...
Achievement rate of blood pressure control <130/80 mmHg as the core metric of implementation hypertension, based on the new JSH2025 and AHA/ACC2025 guidelines
Recent updates to international hypertension guidelines have converged toward a therapeutic target of <130/80 mmHg, as reflected in the JSH2025, AHA/ACC2025, and ESC2024 recommendations. Strong evi...
Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)
Japan has long maintained a robust national health system with universal health coverage and accessible antihypertensive therapy. Nevertheless, population-level blood pressure (BP) control remains ...
The new blood pressure target, a new era: individualized management and precision rooted in clinical decision in JSH2025
Very recently, the Japanese Society of Hypertension Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025 (JSH2025) have recommended a single blood pressure (BP) target of ...
Latest Developments
Recent developments in hypertension research include upcoming scientific sessions in October 2026 focusing on the latest advancements, a new drug, baxdrostat, showing unprecedented 24-hour blood pressure control by reducing aldosterone levels, and ongoing updates to clinical guidelines emphasizing team-based care, home monitoring, and new treatment strategies, as well as recent clinical trials and reviews highlighting the importance of emerging evidence in managing high blood pressure (professional.heart.org, UCL News, JACC, nature.com, jmir.org).
Sources
Frequently Asked Questions
What are the key recommendations in JNC 7 for hypertension management?
Chobanian et al. (2003) in 'The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>' recommend focusing on systolic blood pressure of 140 mm Hg or higher in persons older than 50 years. The report provides an evidence-based approach to prevention, detection, evaluation, and treatment. It emphasizes new guidelines for clinical practice.
How do ESH/ESC guidelines address arterial hypertension?
Mancia et al. (2013) in '2013 ESH/ESC Guidelines for the management of arterial hypertension' present views based on available evidence for health professionals. The guidelines encourage full consideration in clinical judgment without overriding individual decisions. They cover management strategies with 13,631 citations.
What risk factors contribute to myocardial infarction according to INTERHEART?
Yusuf et al. (2004) in 'Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study' identify hypertension alongside abnormal lipids, smoking, diabetes, abdominal obesity, psychosocial factors, and others as accounting for most myocardial infarction risk worldwide. These factors apply to both sexes and all ages across regions. The study has 11,746 citations.
What is the predicted creatinine clearance formula?
Cockcroft and Gault (1976) in 'Prediction of Creatinine Clearance from Serum Creatinine' developed a formula for adult males adjusted 15% less for females, based on age and 24-hour creatinine excretion in 249 patients aged 18-92. The formula predicts creatinine clearance from serum creatinine values. It has 15,271 citations and aids hypertension-related kidney assessments.
What do recent guidelines recommend for blood pressure targets?
The 2025 AHA/ACC guideline and JSH2025 recommend a target of <130/80 mmHg, supported by trials like SPRINT and STEP. Achievement rates of this target serve as a core metric for hypertension implementation. These updates converge on intensive control benefits.
Open Research Questions
- ? How does usual blood pressure at different ages predict vascular mortality across populations, as hinted in Lewington et al. (2002)?
- ? What are the long-term effects of stopping ACE inhibitors/ARBs in advanced kidney disease patients with hypertension?
- ? How do psychosocial factors and abdominal obesity modify hypertension's role in global myocardial infarction risk?
- ? What precision approaches can individualize blood pressure targets below 130/80 mmHg across comorbidities?
- ? How effective is renal denervation in resistant hypertension cases linked to diabetes mellitus?
Recent Trends
Guidelines have shifted to a <130/80 mmHg target in 2025 AHA/ACC and JSH2025 preprints, backed by SPRINT and STEP trials showing intensive control benefits.
Baxdrostat emerged as a treatment for resistant high blood pressure in a University College London study reported August 31, 2025.
Tools like DHIS2 hypertension package and cuffless BP estimation benchmarks via PPG and smartwatches reflect monitoring advances.
Research Blood Pressure and Hypertension Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Blood Pressure and Hypertension Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers